Empower Pharmacy FDA Record
- Latest inspection OAI · Nov 14, 2025
- Last warning letter 2026
Empower Pharmacy has 4 FDA recalls, 8 inspections, 0 510(k) clearances and 5 compliance actions on record. FDA has issued 5 warning letters to Empower Pharmacy, the most recent on Sep 18, 2026. FDA has published 7 Form 483s for Empower Pharmacy.
- Latest recall
- D-0420-2025 · Class II · May 2, 2025
- Latest inspection
- Nov 14, 2025 · OAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 4 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 8 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 5 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Empower Pharmacy: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 1 | 0 | 0 |
| 2025 | 1 | 1 | 2 | 1 | 0 |
| 2024 | 2 | 2 | 0 | 2 | 0 |
| 2023 | 1 | 1 | 0 | 1 | 0 |
| 2022 | 1 | 1 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 1 | 0 | 0 |
| 2020 | 1 | 1 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 1 | 0 | 0 |
Reviewing Empower Pharmacy as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Empower Pharmacy yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Empower Pharmacy FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Sep 18, 2026 · Letter on fda.gov | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug | Center for Drug Evaluation and Research (CDER) | |
| Apr 2, 2025 · Record page | |||
| Apr 2, 2025 · Letter on fda.gov | Compounding Pharmacy/Adulterated Drug Products | Center for Drug Evaluation and Research (CDER) | |
| Oct 15, 2021 · Letter on fda.gov | Compounding Pharmacy/Adulterated Drug Products | Office of Pharmaceutical Quality Operations, Division II | |
| May 25, 2017 · Record page |
Empower Pharmacy Form 483s
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0420-2025 | Class II | Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial… | May 2, 2025 |
| D-0663-2024 | Class II | Pyridoxine HCL (B6) Injection Solution, 100mg/mL, 30 mL Sterile Multiple-Dose Vial, For IM or IV use… | Sep 5, 2024 |
| D-0630-2024 | Class II | Empower Pharmacy, Estradiol Cypionate Injection, 10mg/mL, 5mL Sterile Multiple Dose Vial, For IM or… | Aug 2, 2024 |
| D-0865-2023 | Class II | ASCORBIC ACID PRESERVED INJECTION SOLUTION, 500 mg/mL, 30 mL Sterile Multiple-Dose Vial, RX ONLY… | May 12, 2023 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 14, 2025 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3021758709 |
| Oct 4, 2024 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3021758709 |
| Aug 28, 2024 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3011887629 |
| Dec 1, 2023 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3021758709 |
| Aug 5, 2022 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3011887629 |
| Mar 6, 2020 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3011887629 |
| Jan 24, 2018 | Houston, TX | Drugs | Voluntary Action Indicated (VAI) | 3011887629 |
| Nov 25, 2015 | Houston, TX | Drugs | Official Action Indicated (OAI) | 3011887629 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 5 compliance actions under Empower Pharmacy: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3021758709 | Houston, TX | 3 | Nov 14, 2025 |
| FEI 3011887629 | Houston, TX | 5 | Aug 28, 2024 |
Empower Pharmacy and the FDA: common questions
Has Empower Pharmacy received an FDA warning letter?
Yes. FDA has issued 5 warning letters to Empower Pharmacy. The most recent is dated Sep 18, 2026, with the subject "CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug".
Has Empower Pharmacy received an FDA Form 483?
FDA has published 7 Form 483s for Empower Pharmacy in its reading room, the most recent dated Nov 15, 2025. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Empower Pharmacy?
The most recent FDA inspection on file ended Nov 14, 2025 at Houston, TX and was classified OAI. FDA has 8 inspections of Empower Pharmacy on file, 7 of them classified OAI (official action indicated).
Has Empower Pharmacy had an FDA recall?
Yes. Empower Pharmacy has 4 FDA recalls on record. The most recent started May 2, 2025.
Need more than this page shows? Ask about Empower Pharmacy in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.